Suppr超能文献

1α,25-二羟基维生素D3通过抑制解偶联蛋白-2上调减轻氰化物诱导的神经毒性。

1Alpha,25-dihydroxyvitamin D3 attenuates cyanide-induced neurotoxicity by inhibiting uncoupling protein-2 up-regulation.

作者信息

Li L, Prabhakaran K, Zhang X, Zhang L, Liu H, Borowitz J L, Isom G E

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana, USA.

出版信息

J Neurosci Res. 2008 May 1;86(6):1397-408. doi: 10.1002/jnr.21596.

Abstract

1Alpha,25-dihydroxyvitamin D(3) (VD(3)) is a neuroprotectant that can reduce cytotoxicity produced by a variety of toxicants. The mechanism of the neuroprotection was studied in rat primary cortical cells in which Wy14,643, an agonist of peroxisome proliferator activated receptor-alpha (PPARalpha), enhances cyanide (KCN) neurotoxicity. In this cell model, Wy14,643 pretreatment enhanced cyanide-induced cell death, and the increased cell death was linked to up-regulation of uncoupling protein-2 (UCP-2). VD(3) reversed cyanide-induced mitochondrial dysfunction in cells pretreated with Wy14,643, as reflected by restoration of cellular ATP and mitochondrial membrane potential (DeltaPsi(m)). Analysis of cellular state 4 oxygen consumption showed increased mitochondrial uncoupling accompanied by up-regulation of UPC-2. The uncoupling was attenuated by prior treatment with VD(3). The interaction of VD(3) with UCP-2 was attributed to increased expression of IkappaB, an inhibitor of NF-kappaB (transcription factor that regulates UCP-2 expression). The increased IkappaB levels lead to reduced nuclear translocation and DNA binding of nuclear factor-kappaB. The role of oxidative stress in the response was then evaluated. Cotreatment with Wy14,643 and cyanide markedly increased reactive oxygen species generation and decreased reduced glutathione levels. The oxidative stress was blocked by VD(3) pretreatment. It was concluded that VD(3) blocks Wy14,643 enhancement of cyanide neurotoxicity by suppressing the redox-mediated transcriptional up-regulation of UCP-2, resulting in reduced mitochondrial proton leak and stabilization of mitochondrial function.

摘要

1α,25-二羟基维生素D(3)(VD(3))是一种神经保护剂,可降低多种毒物产生的细胞毒性。在大鼠原代皮层细胞中研究了其神经保护机制,其中过氧化物酶体增殖物激活受体-α(PPARα)激动剂Wy14,643可增强氰化物(KCN)的神经毒性。在该细胞模型中,Wy14,643预处理增强了氰化物诱导的细胞死亡,且细胞死亡增加与解偶联蛋白-2(UCP-2)的上调有关。VD(3)可逆转Wy14,643预处理细胞中氰化物诱导的线粒体功能障碍,这可通过细胞ATP和线粒体膜电位(ΔΨm)的恢复来体现。对细胞状态4氧消耗的分析表明,线粒体解偶联增加,同时UPC-2上调。VD(3)预先处理可减弱这种解偶联。VD(3)与UCP-2的相互作用归因于IkappaB表达增加,IkappaB是NF-κB(调节UCP-2表达的转录因子)的抑制剂。IkappaB水平升高导致核因子-κB的核转位和DNA结合减少。随后评估了氧化应激在该反应中的作用。Wy14,643与氰化物共同处理显著增加了活性氧的产生,并降低了还原型谷胱甘肽水平。VD(3)预处理可阻断氧化应激。得出的结论是,VD(3)通过抑制UCP-2的氧化还原介导的转录上调来阻断Wy14,643增强的氰化物神经毒性,从而减少线粒体质子泄漏并稳定线粒体功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验